Mode
Text Size
Log in / Sign up
N/A N=431 Randomized Double-blind Supportive Care

Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS)

Prostate Cancer

Enrolled (actual)
431
Serious AEs
0.0%
Results posted
Oct 2021
Primary outcome: Primary: Adaptive Coping — -0.089; -0.013 score on a scale — p=.9634

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
PROGRESS (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
Fox Chase Cancer Center
Primary completion
Jun 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Adaptive Coping
-0.089; -0.013 .9634
SECONDARY
Physical Functioning - Urinary Incontinence
9.240; 10.750 .5214
SECONDARY
Physical Functioning - Urinary Irritation
10.063; 7.979 .4875
SECONDARY
Physical Functioning - Bowel
1.479; 3.119 .7938
SECONDARY
Physical Functioning - Sexual Functioning
4.793; 3.046 .6765
SECONDARY
Interpersonal Concerns - Medical Interactions
-0.311; -0.531 .7061
SECONDARY
Interpersonal Concerns - Marital Interactions
-0.042; 0.182 .7593

Summary

The purpose of this study is to test how well an online program designed to help prostate cancer survivors cope with changes caused by their cancer or treatment works compared to standard print educational materials from the National Cancer Institute (NCI).

Eligibility Criteria

Inclusion Criteria

  • Received a diagnosis of localized disease confined to the prostate, with no regional lymph node or distant metastasis (stages T1, T1a, T1b, T2, T2a, T2b; T2c [3]);
  • Within one year completion of either radical prostatectomy or radiation therapy(external beam radiation therapy or brachytherapy);
  • Have access to a personal computer with Internet access (either in home or at a community center);
  • 18 years of age or older;
  • Able to communicate in English
  • Able to give consent

Exclusion Criteria

  • Unable to use a computer
  • Unable to communicate in English

Exclusion Criteria

  • unable to use a computer
  • unable to communicate in English
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02224482). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search